MoviPrep - Bowel Prep
MoviPrep is a prescription medicine a person drinks before a colonoscopy. The liquid, polyethylene glycol (also called PEG), flushes waste from the colon,
allowing the physician to get a clear view of the colon wall during the colonoscopy procedure. Drinking this liquid before the colonoscopy is called
the bowel preparation (bowel prep) or colonoscopy preparation (colon prep).
There are several liquid PEG bowel preps available, but many require people to drink 4 liters of the prep solution. MoviPrep is different, because it
only requires them to drink 2 liters of the prep solution. While it requires the patient to drink less solution,
MoviPrep is similar in its effectiveness to 4–liter liquid preps.
Many PEG colon–prep regimens are plagued by bad–tasting liquids, but 86% of people who took MoviPrep rated the taste "acceptable" or "satisfactory."1
MoviPrep also does not require the use of bisacodyl tablets, thus avoiding bisacodyl–associated abdominal cramping.
To learn more about MoviPrep, how this bowel prep is used, or more about colon cancer, browse the menu to the left or speak to your healthcare provider.
References
Please click a link below to be taken to that area
MoviPrep Physician Resource Center
U.S. Pharmacists
MOVIPREP® (PEG-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid for oral solution) is indicated for cleansing of the
colon as a preparation for colonoscopy in adults 18 years of age or older. MOVIPREP is contraindicated in patients who have had a severe hypersensitivity reaction
to any of its components. MOVIPREP should be used with caution in patients using concomitant medications that increase the risk of electrolyte abnormalities, in patients with known or suspected hyponatremia,
severe ulcerative colitis, ileus, gastrointestinal obstruction or perforation, gastric retention, toxic colitis, toxic megacolon, or glucose-6-phosphate dehydrogenase deficiency. In clinical trials, abdominal
distention, anal discomfort, thirst, nausea, and abdominal pain were the most common adverse reactions to MOVIPREP administration. MOVIPREP contains a maximum of 2.33 mg of phenylalanine per treatment.
Consult with your physician to see if this product is right for you.
For complete Prescribing Information, please click here.
For product information, adverse event reports, and product complaint reports please call:
Salix Product Information Call Center
Phone: 1-800-508-0024
Fax: 1-510-595-8183
Email: